Zacks Investment Research upgraded shares of DLH (NASDAQ:DLHC) from a hold rating to a buy rating in a research report report published on Monday. Zacks Investment Research currently has $7.00 price objective on the business services provider’s stock.
According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “
Several other analysts have also recently commented on the company. TheStreet raised DLH from a c rating to a b- rating in a research report on Wednesday, November 1st. Canaccord Genuity reaffirmed a buy rating and issued a $7.00 target price on shares of DLH in a research report on Friday, October 13th. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The company has an average rating of Buy and an average target price of $7.17.
In related news, major shareholder Wynnefield Partners Small Cap sold 150,000 shares of the stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $6.15, for a total transaction of $922,500.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 25.90% of the stock is currently owned by company insiders.
Several large investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP purchased a new stake in shares of DLH during the third quarter worth $121,000. Essex Investment Management Co. LLC raised its holdings in shares of DLH by 149.2% during the third quarter. Essex Investment Management Co. LLC now owns 71,887 shares of the business services provider’s stock worth $466,000 after acquiring an additional 43,043 shares in the last quarter. Finally, Commonwealth Equity Services Inc purchased a new stake in shares of DLH during the third quarter worth $2,342,000. Institutional investors and hedge funds own 54.33% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was first posted by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.com-unik.info/2018/01/09/dlh-dlhc-rating-increased-to-buy-at-zacks-investment-research.html.
DLH Holdings Corp. provides healthcare and social services in the United States. It offers defense and veterans health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services. The company also provides a range of human services and solutions, which consists of educational and environmental support services for the underserved children and youth comprising health, nutritional, parental, and behavioral services; and IT system architecture design, migration plan, and ongoing maintenance services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DLH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DLH and related companies with MarketBeat.com's FREE daily email newsletter.